EUROLyser is formerly owned by ARCHIMED, through MED Platform I, since 2019.

When did ARCHIMED acquire EUROLyser?

ARCHIMED acquired EUROLyser in 2019 and exited after 3 years.

Has EUROLyser been sold?

Yes. EUROLyser was exited in 2022 via Trade Sale.

Home/Companies/MedTech/EUROLyser

EUROLyser

MedTech·

Austria·Exited 2022·Held 3yr

EUROLyser is a diagnostics, animal & environmental health company, headquartered in Austria.

Entry

2019

Hold

3yr

Exit

2022

Est. EV

–

Investor

ARCHIMED

Key facts

HQAustria

SectorDiagnostics, Animal & Environmental Health

Founded in 2005 and based in Austria, EUROLyser is a leading diagnostics company that engineers and designs point-of-care testing devices…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Exit details: type, year, MOIC (buyer on Pro)

Start free

Already a member? Sign in

More from MED Platform I

Other portfolio companies in the same fund.

Ad-Tech Medical Instrument

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Villard

Active

Yotta Capital Partners

France· 2026

Amoena

Active

Apera Asset Management

Germany· 2025

Circlesafe

Active

Odyssée VentureFrance

Last updated April 2026 · Sourced from public filings